Revance Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Nashville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
Revance Therapeutics, Inc. has filed 947 SEC EDGAR filings since 23 Dec 2009

SEC filing history

Showing 501-525 of 946 matching filings.

Per page
25
Current page
21
4

FORM 4

Filing date
18 Jul 2019
Reporting date
16 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
18 Jul 2019
Reporting date
16 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

8-K

Filing date
17 Jul 2019
Reporting date
16 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jul 2019
Reporting date
28 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jul 2019
Reporting date
28 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jul 2019
Reporting date
28 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jun 2019
Reporting date
15 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jun 2019
Reporting date
04 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
06 Jun 2019
Reporting date
04 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

8-K

Filing date
06 Jun 2019
Reporting date
06 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-193154

CT ORDER filing

Filing date
17 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 May 2019
Reporting date
09 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 May 2019
Reporting date
09 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 May 2019
Reporting date
09 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 May 2019
Reporting date
09 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 May 2019
Reporting date
09 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 May 2019
Reporting date
09 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

8-K

Filing date
08 May 2019
Reporting date
08 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36297

DEF 14A

Filing date
25 Mar 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Mar 2019
Reporting date
15 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Mar 2019
Reporting date
15 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Mar 2019
Reporting date
14 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36297

CT ORDER filing

Filing date
18 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .